A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
- Geens, W. (Speaker)
- Schwarze, J. K. (Contributor)
- Bertels, C. (Contributor)
- Jens Tijtgat (Contributor)
- Awada, G. (Contributor)
- F Vaeyens (Contributor)
- Louise Cras (Contributor)
- Vanbinst, A. (Contributor)
- Everaert, H. (Contributor)
- Michotte, A. (Contributor)
- Toon Janssen (Contributor)
- Ben Caljon (Contributor)
- Thomas Cauwenbergh (Contributor)
- Bruneau, M. (Contributor)
- Forsyth, R. (Contributor)
- Tuyaerts, S. (Contributor)
- Neyns, B. (Contributor)
- Duerinck, J. (Contributor)
Activiteit: Talk or presentation at a conference